EDDA Receives FDA Clearance For Its IQQA(R)-Liver Software For Multiphase MDCT
17th Nov 2006, 08:24 GMT
EDDA Technology today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its IQQA(R)-Liver software, an image analysis system that provides diagnostic decision support for physicians' evaluation of hepatic lesions using multiphase Multi-Detector CT (MDCT). [click link for full article]
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes